Leiden Improvement of MIgraine Therapy in general practice

ISRCTN ISRCTN72421511
DOI https://doi.org/10.1186/ISRCTN72421511
Secondary identifying numbers N/A
Submission date
22/01/2007
Registration date
22/01/2007
Last edited
10/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J W Blom
Scientific

Leiden University Medical Center (LUMC)
Department of Public Health and Primary Care
Postzone V-0-P
P.O. Box 9600
Leiden
2300 RC
Netherlands

Phone +31 (0)71 526 8406
Email J.W.Blom@lumc.nl

Study information

Study designRandomised, controlled, parallel group, multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymLIMIT-study
Study objectivesThe aim of the study is to optimise therapy of migraine patients, according to the Dutch General Practitioner (GP) Guideline for headache and consequently reduce the use of triptans. The project will explore the costs and effects of a proactive approach of patients with triptan use by GPs.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMigraine
InterventionIntervention:
Proactive stepped approach based on the Dutch GP Guideline:
Step one: a letter to invite patients for consultation.
Step two: a visit to the GP, who can give information about headache and therapy, reduce/stop the triptans, prescribe prophylactic therapy or reconsider the diagnosis of migraine.

Control group:
Care as usual.
Intervention typeOther
Primary outcome measureHeadache Impact Test (HIT-6) score at baseline and after three, six, nine and 12 months.
Secondary outcome measures1. The health-related quality of life (self reported EuroQoL [EQ-5D] questionnaire and visual analogue scale)
2. Migraine characteristics
3. Medication use
4. Social effects of migraine including absence at work

Measured at baseline and after three, six, nine and 12 months.
Overall study start date01/03/2007
Completion date01/03/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participants600
Key inclusion criteriaPatients in general practice using more than or equal to 24 Defined Daily Doses (DDD) triptans (or more than or equal to six DDDs in the last three months), enlisted in 60 general practices, that are part of LEON (Leiden Eerstelijns OnderzoeksNetwerk), managed by the department of Public Health and Primary Care.
Key exclusion criteria1. Younger than 18 years
2. Cognitive impairment
3. Psychiatric illness
4. Terminal illness
5. Non-Dutch speaking
Date of first enrolment01/03/2007
Date of final enrolment01/03/2010

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Leiden University Medical Center (LUMC)
Leiden
2300 RC
Netherlands

Sponsor information

Leiden University Medical Center (LUMC) (The Netherlands)
Hospital/treatment centre

Department of Public Health and Primary Care
P.O. Box 9600
Leiden
2300 RC
Netherlands

Website http://www.lumc.nl/english/start_english.html
ROR logo "ROR" https://ror.org/05xvt9f17

Funders

Funder type

Research organisation

Stichting Nuts Ohra (The Netherlands)

No information available

Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 06/03/2012 Yes No